GlassScriptPhysician profile
Morgan S Kellogg
NPI 1730522079
$4,472.66
in general payments reported to CMS, 2019-2025
29 companies · $585 in 2025
The $585 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $332 · 2020: $209 · 2021: $284 · 2022: $310 · 2023: $2,226 · 2024: $528 · 2025: $585.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,856 · Travel and Lodging: $1,482.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,856.00 |
| Travel and Lodging | $1,482.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,802.66 | 2023-2024 | Avvigo Guidance System |
| Medtronic, INC. | $475.35 | 2021-2025 | In.Pact Admiral, Onyx Frontier, Pulseselect |
| E.R. Squibb & Sons, L.L.C. | $221.54 | 2021-2025 | Camzyos, Eliquis |
| Novartis Pharmaceuticals Corporation | $217.80 | 2020-2025 | |
| Amgen INC. | $195.14 | 2022-2024 | Repatha |
| Merck Sharp & Dohme LLC | $184.62 | 2021-2025 | Verquvo, Winrevair |
| Ge Healthcare | $173.71 | 2020 | |
| Medtronic Vascular, INC. | $162.32 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $104.73 | 2021-2024 | Xarelto |
| Abbott Laboratories | $104.05 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $101.73 | 2021-2025 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $97.08 | 2021-2024 | Farxiga, Wainua |
| Cardinal Health 200 LLC | $91.80 | 2019 | |
| Siemens Medical Solutions USA, INC. | $87.57 | 2024 | Somatom Pro.Pulse |
| Pfizer INC. | $67.30 | 2023 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $57.15 | 2023-2024 | Impella |
| Actelion Pharmaceuticals US, INC. | $52.57 | 2023 | Uptravi, Opsumit |
| Biosense Webster, INC. | $41.95 | 2025 | Carto 3 |
| Shockwave Medical, INC | $36.75 | 2024-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Impulse Dynamics (USA) INC. | $26.05 | 2023 | Optimizer |
| Bridgebio Pharma, INC. | $25.60 | 2025 | Attruby |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $24.04 | 2025 | Lifevest |
| Cardiovascular Systems INC. | $22.97 | 2019 | |
| Baxter Healthcare | $19.23 | 2025 | Hillrom - Cardiac Ambulatory Monitor |
| Novo Nordisk INC | $17.91 | 2024 | Wegovy |
| Heartflow, INC. | $17.43 | 2025 | |
| Lilly USA, LLC | $16.85 | 2025 | Mounjaro |
| Change Healthcare Technologies, LLC | $15.27 | 2023 | Change Healthcare Radiology Solutions |
| Abbvie INC. | $11.49 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Morgan Kellogg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.